Evidence map›Paper›PMID 28392699›Full record

ArticleTherapeutics and clinical risk management2017

Comparison of prophylactic effect of UGIB and effects on platelet function between PPIs and H

Zhan-Miao Yi, Ting-Ting Qiu, Yuan Zhang, Zhi-Yan Liu, Suo-Di Zhai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutics and clinical risk management, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Zhan-Miao YiDepartment of Pharmacy, Peking University Third Hospital, Beijing.
Ting-Ting QiuDepartment of Pharmacy, Peking University Third Hospital, Beijing; Department of Pharmacy, China Pharmaceutical University, Nanjing, People's Republic of China.
Yuan ZhangDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
Zhi-Yan LiuDepartment of Pharmacy, Peking University Third Hospital, Beijing.
Suo-Di ZhaiDepartment of Pharmacy, Peking University Third Hospital, Beijing.
Peking University · CNMcMaster University · CAPeking University Third Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe compared prophylactic effects of proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H

methodsRandomized controlled trials and cohort studies comparing PPIs with H

resultsTwelve clinical trials (n=3,301) met the inclusion criteria. Compared to H

conclusionLimited evidence indicates that PPIs were better than H

Indexed as

dual-antiplatelet therapyhistamine-2 receptor antagonistsmeta-analysisplatelet functionproton pump inhibitorsupper gastrointestinal bleeding

Identifiers

PMID28392699
PMCPMC5373835
OpenAlexW2598641184

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.